During the current 5-years’ plan, the city will build a new generation of high-tech zones in this industry segment, relying on over 60 bio-pharmaceutical companies with total annual sales of 22,6 billion Yuan and China’s top marine drug base.
CAS news release, April 1, 2016
Qingdao strives to become China’s top marine biomedical research and pharmaceutical industry city